A Scientific American Reflects On The Scientific Revolution

FLANAGAN’S VERSION: A Spectator’s Guide to Science on the Eve of the 21st Century Dennis Flanagan Alfred A. Knopf, New York, 1988; 230 pages; $18.95 For 40 years and more, Dennis Flanagan has been struggling to popularize the scientific revolution that we are in. Now that is a long time. It’s about enough time, for example, for a northeastern maple to mature, be cut down with an amateur’s handsaw, sawn into lengths, split, stacked, dried, laid in the fireplace, and

Written byVictor Mcelheny
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLANAGAN’S VERSION:
A Spectator’s Guide
to Science on the Eve of the 21st Century

Dennis Flanagan
Alfred A. Knopf, New York, 1988;
230 pages; $18.95

For 40 years and more, Dennis Flanagan has been struggling to popularize the scientific revolution that we are in. Now that is a long time.

It’s about enough time, for example, for a northeastern maple to mature, be cut down with an amateur’s handsaw, sawn into lengths, split, stacked, dried, laid in the fireplace, and lighted to accompany a good story. It’s also about enough time for our synthetic view of man-kind, the earth, and the universe— the one that we build out of snippets of book learning, conversation, and journalism, to expand and change profoundly.

In that view today, we see recent human evolution against a vast background of evolving forces, particles, galaxies, stars, planets, features on the surface of our own planet, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies